Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-16

Clinical Trial Update: Prebiotics in Prevention of Atopy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating prebiotics for the prevention of atopy in individuals at risk for atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Federico II University | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED